Work

Abstract 7186: Anti-cancer activity of potent and selective EP300 degradation in hematological malignancies

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-7186

Authors: Claudia Dominici, Qianhe Zhou, Laura La Bonte, Mark Zimmerman, Mei Yun Lin, Wesley Austin

Institution: Foghorn Therapeutics (United States)

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409636785

Cites:

Cited by: 1

Related to: 10